Net Income (Loss) Attributable to Parent in USD of Tengjun Biotechnology Corp. from Q3 2010 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Tengjun Biotechnology Corp. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q3 2010 to Q2 2023.
  • Tengjun Biotechnology Corp. Net Income (Loss) Attributable to Parent for the quarter ending 30 Jun 2023 was -$453,112.000, a 112% decline year-over-year.
  • Tengjun Biotechnology Corp. annual Net Income (Loss) Attributable to Parent for 2022 was $11,346,841.000.
  • Tengjun Biotechnology Corp. annual Net Income (Loss) Attributable to Parent for 2021 was -$747,525.000, a 8.2% decline from 2020.
  • Tengjun Biotechnology Corp. annual Net Income (Loss) Attributable to Parent for 2020 was -$690,886.000, a 1054% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Tengjun Biotechnology Corp. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$453,112 -$4,374,255 -1.1% 01 Apr 2023 30 Jun 2023 10-Q 15 Aug 2023
Q1 2023 $362,667 +$143,844 +65.7% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023
Q3 2022 $7,313,445 $3,425,522 +$3,532,824 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $3,780,621 $3,921,143 +$4,143,224 01 Apr 2022 30 Jun 2022 10-Q 15 Aug 2023
Q1 2022 -$362,603 $218,823 +$384,922 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 -$747,525 -$252,043 +$397,193 +61.2% 01 Oct 2021 31 Dec 2021 10-K 17 Apr 2023
Q3 2021 -$1,144,718 -$107,302 -$95,342 -8% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$1,049,376 -$222,081 -$209,181 -16.2% 01 Apr 2021 30 Jun 2021 10-Q/A 16 Sep 2022
Q1 2021 -$840,195 -$166,099 -$149,309 -8.9% 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022
Q4 2020 -$690,886 -$649,236 -$628,048 -29.6% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 -$62,838 -$11,960 -$266 -2.3% 01 Jul 2020 30 Sep 2020 10-Q 20 Oct 2021
Q2 2020 -$62,572 -$12,900 -$1,381 -12% 01 Apr 2020 30 Jun 2020 10-Q 20 Jul 2021
Q1 2020 -$61,191 -$16,790 -$1,326 -8.6% 01 Jan 2020 31 Mar 2020 10-Q 16 Apr 2021
Q4 2019 -$59,865 -$21,188 -$10,307 -94.7% 01 Oct 2019 31 Dec 2019 10-K 17 Feb 2021
Q3 2019 -$49,558 -$11,694 -$950 -8.8% 01 Jul 2019 30 Sep 2019 10-Q 20 Oct 2020
Q2 2019 -$48,608 -$11,519 +$469 +3.9% 01 Apr 2019 30 Jun 2019 10-Q 20 Oct 2020
Q1 2019 -$49,077 -$15,464 -$1,271 -9% 01 Jan 2019 31 Mar 2019 10-Q 20 Oct 2020
Q4 2018 -$47,806 -$10,881 -$4,161 -61.9% 01 Oct 2018 31 Dec 2018 10-K 28 Feb 2020
Q3 2018 -$43,645 -$10,744 -$911 -9.3% 01 Jul 2018 30 Sep 2018 10-Q 25 Oct 2019
Q2 2018 -$42,734 -$11,988 +$729 +5.7% 01 Apr 2018 30 Jun 2018 10-Q 25 Oct 2019
Q1 2018 -$43,463 -$14,193 +$4,768 +25.1% 01 Jan 2018 31 Mar 2018 10-Q 25 Oct 2019
Q4 2017 -$48,231 -$6,720 +$17,275 +72% 01 Oct 2017 31 Dec 2017 10-K 08 Mar 2019
Q3 2017 -$65,506 -$9,833 +$5,251 +34.8% 01 Jul 2017 30 Sep 2017 10-Q 16 Oct 2018
Q2 2017 -$70,757 -$12,717 -$2,368 -22.9% 01 Apr 2017 30 Jun 2017 10-Q 27 Jul 2018
Q1 2017 -$68,389 -$18,961 -$7,725 -68.8% 01 Jan 2017 31 Mar 2017 10-Q 03 May 2017
Q4 2016 -$60,664 -$23,995 -$7,892 -49% 01 Oct 2016 31 Dec 2016 10-K 07 Mar 2018
Q3 2016 -$52,772 -$15,084 -$1,853 -14% 01 Jul 2016 30 Sep 2016 10-Q 27 Oct 2017
Q2 2016 -$50,919 -$10,349 +$10,900 +51.3% 01 Apr 2016 30 Jun 2016 10-Q 03 Aug 2017
Q1 2016 -$61,819 -$11,236 +$12,890 +53.4% 01 Jan 2016 31 Mar 2016 10-Q 03 May 2017
Q4 2015 -$74,709 -$16,103 -$29,572 -2.2% 01 Oct 2015 31 Dec 2015 10-K 27 Mar 2017
Q3 2015 -$45,137 -$13,231 +$18,592 +58.4% 01 Jul 2015 30 Sep 2015 10-Q 01 Nov 2016
Q2 2015 -$63,729 -$21,249 +$10,574 +33.2% 01 Apr 2015 30 Jun 2015 10-Q 29 Jul 2016
Q1 2015 -$74,303 -$24,126 +$34,061 +58.5% 01 Jan 2015 31 Mar 2015 10-Q 02 May 2016
Q4 2014 -$108,364 $13,469 +$29,783 01 Oct 2014 31 Dec 2014 10-Q 02 May 2016
Q3 2014 -$138,147 -$31,823 -$30,823 -30.8% 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2014
Q2 2014 -$107,324 -$31,823 -$30,823 -30.8% 01 Apr 2014 30 Jun 2014 10-Q 13 Nov 2015
Q1 2014 -$76,501 -$58,187 -$55,187 -18.4% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015
Q4 2013 -$21,314 -$16,314 -$16,314 01 Oct 2013 31 Dec 2013 10-K 14 Apr 2015
Q3 2013 -$5,000 -$1,000 +$6,155 +86% 01 Jul 2013 30 Sep 2013 10-Q 12 Nov 2014
Q2 2013 -$11,155 -$1,000 +$7,959 +88.8% 01 Apr 2013 30 Jun 2013 10-Q 19 Aug 2014
Q1 2013 -$19,114 -$3,000 +$15,056 +83.4% 01 Jan 2013 31 Mar 2013 10-Q 04 Jun 2014
Q4 2012 -$34,170 $0 +$952 01 Oct 2012 31 Dec 2012 10-K 09 Apr 2014
Q3 2012 -$35,122 -$7,155 +$222 +3% 01 Jul 2012 30 Sep 2012 10-Q 19 Nov 2013
Q2 2012 -$35,344 -$8,959 -$3,794 -73.5% 01 Apr 2012 30 Jun 2012 10-Q 13 Aug 2013
Q1 2012 -$31,550 -$18,056 -$6,793 -60.3% 01 Jan 2012 31 Mar 2012 10-Q 16 May 2013
Q4 2011 -$24,757 -$952 01 Oct 2011 31 Dec 2011 10-K/A 10 May 2013
Q3 2011 -$7,377 -$3,203 -76.7% 01 Jul 2011 30 Sep 2011 10-Q 15 Nov 2012
Q2 2011 -$5,165 01 Apr 2011 30 Jun 2011 10-Q/A 09 Aug 2012
Q1 2011 -$11,263 01 Jan 2011 31 Mar 2011 10-Q 19 Apr 2012
Q3 2010 -$4,174 01 Jul 2010 30 Sep 2010 10-Q 19 Oct 2011

Tengjun Biotechnology Corp. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $11,346,841* +$12,094,366 01 Jan 2022 31 Dec 2022 10-K 17 Apr 2023
2021 -$747,525 -$56,639 -8.2% 01 Jan 2021 31 Dec 2021 10-K 17 Apr 2023
2020 -$690,886 -$631,021 -10.5% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
2019 -$59,865 -$12,059 -25.2% 01 Jan 2019 31 Dec 2019 10-K 17 Feb 2021
2018 -$47,806 +$425 +0.88% 01 Jan 2018 31 Dec 2018 10-K 28 Feb 2020
2017 -$48,231 +$12,433 +20.5% 01 Jan 2017 31 Dec 2017 10-K 08 Mar 2019
2016 -$60,664 +$14,045 +18.8% 01 Jan 2016 31 Dec 2016 10-K 07 Mar 2018
2015 -$74,709 +$33,655 +31.1% 01 Jan 2015 31 Dec 2015 10-K 27 Mar 2017
2014 -$108,364 -$87,050 -4.1% 01 Jan 2014 31 Dec 2014 10-Q 02 May 2016
2013 -$21,314 +$12,856 +37.6% 01 Jan 2013 31 Dec 2013 10-K 14 Apr 2015
2012 -$34,170 -$9,413 -38% 01 Jan 2012 31 Dec 2012 10-K 09 Apr 2014
2011 -$24,757 01 Jan 2011 31 Dec 2011 10-K/A 10 May 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.